Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia

Sara N. Salerno, Janice Bernhardt, Matthew Laughon, Ravi Ramesh Jhaveri, Matthew Massaro, Daniel Gonzalez

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

We report here the first pharmacokinetic-pharmacodynamic relationship for ceftaroline in a preterm infant born at <28 weeks' gestational age who was given ceftaroline (8.5 mg/kg every 8 hours) for pneumonia attributable to methicillin-resistant Staphyloccocus aureus. This dose of ceftaroline was adequate to achieve the pharmacodynamic endpoint associated with efficacy for methicillin-resistant Staphyloccocus aureus.

Original languageEnglish (US)
Pages (from-to)342-345
Number of pages4
JournalJournal of the Pediatric Infectious Diseases Society
Volume7
Issue number4
DOIs
StatePublished - Dec 3 2018

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia'. Together they form a unique fingerprint.

Cite this